Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPA: Stereotactic Prostate Radiotherapy +/- ADT
NCT05019846Phase 3Recruiting
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa). Started Sep 2021; status: recruiting.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05019846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019846.